Actively Recruiting
Autonomous At Home Thanks to a Connected Device and Occupational Therapy Support
Led by Université Catholique de Louvain · Updated on 2025-02-11
3900
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
This research aims to evaluate the 'Bien chez Moi 2.0' (BCM2.0) programme, which combines assistive devices with occupational therapy support to help older adults remain at home safely. The study focuses on understanding how, for whom, and why these interventions work and under what conditions. It also assesses their impact on autonomy, life goals, feelings of security, emergency hospital use, and delaying admission to nursing homes. Participants receive the BCM2.0 programme, which provides occupational therapy sessions alongside assistive devices tailored to support aging in place. The study includes multiple components such as descriptive quantitative data collection, qualitative interviews, focus groups with therapists, and a prospective cohort study following beneficiaries for up to 12 months. Additional analyses explore barriers and facilitators to implementation and ethical considerations through community meetings. During the study, participants are evaluated at enrolment and again six months later using various tools, including the Canadian Occupational Performance Measure (COPM), the Short Falls Efficacy Scale-International (FES-I), health-related quality of life assessments, and monitoring of hospitalizations and nursing home admissions. Researchers also assess the use of assistive devices, sense of security at home, and the ability to perform daily activities. The study's total follow-up duration is up to 12 months, with continued engagement through interviews and observational studies.
CONDITIONS
Brief Title
Autonomous At Home with Occupational Therapy Support and Assistive Devices
Who Can Participate
Eligibility Criteria
You may qualify if you...
- People aged 65 and over
- Living at home in the Walloon and Brussels regions
- Considered frail or at risk of frailty, defined by at least one loss of intrinsic capacity measured by a trained occupational therapist using the ICOPE screening tool
You will not qualify if you...
- People benefiting from other AViQ autonomy programmes of this project are excluded
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 6 months
Participants receive occupational therapy sessions and assistive devices to support aging at home through the BCM2.0 programme.
Baseline visit and 6-month follow-up visit
Duration - Up to 6 months after enrolment
Participants are monitored for outcomes such as quality of life, hospitalisation, and use of assistive devices after receiving occupational therapy support.
6-month follow-up visit
Trial Site Locations
Total: 1 location
1
Ergo2.0
Yvoir, Belgium, B-5530
Actively Recruiting
Research Team
T
Thérèse Van Durme
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here